canchew cbd

› CanChew® Gum is the first CBD hemp oil chewing gum, created using AXIM® Biotechnologies patent for chewing gum as a delivery method for cannabinoids.


Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the website. Links to any informational websites are provided solely as a service to our users.

social networks

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

CanChew® is the world’s first patented controlled-release cannabinoid chewing gum containing 50 mg of hemp oil and 10 mg of CBD.

CanChew Plus™ is a unique industrial hemp based chewing gum that is distinctly different and superior to any other brands of gum on the market. Features listed on the CanChew website include:

About AXIM®
AXIM® Biotechnologies, Inc. (OTC:AXIM) focuses on the research, development and production of cannabinoid-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew Plus™ a CBD-based controlled release chewing gum. A clinical trial with a CanChew Plus™ containing 50 mg of CBD will enter a clinical trial in patients with IBS (irritable bowel syndrome), and MedChew Rx, a combination CBD/THC gum that will be undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. For more information, please visit